We use cookies to make this site work. We'd also like to set optional cookies so we can understand how the site is used and improve it. We will not set optional cookies unless you accept them. You can change your choice at any time from the Cookie settings link in the footer.
Strictly necessary cookies
These cookies are required for the site to work. They store your cookie preferences and keep your session secure. They are exempt from consent under PECR Regulation 6(4) because they are essential to deliver the service you have requested.
Optional cookies
Optional cookies help us understand how the site is used and provide additional features such as analytics, accessibility tools and translation. We will only set them if you accept.
Anti-Obesity Medication Policy
We have started receiving enquiries from patients regarding the prescription of weight loss medication, specifically Tirzepatide (Mounjaro), which was approved by NICE for use on the NHS at the end of December 2024.
Whilst weight loss injections have now been approved on the NHS and roll-out has begun, eligibility criteria are strictly controlled. Unfortunately we have no ability to overrule the NHS criteria so cannot offer appointments with the clinical team to discuss this.
All patients will be contacted by the surgery as and when they become eligible but in most cases this will be a wait of a number of years so please remain patient.